Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data.

D'Cruz D, Eriksson G, Green Y, Hammer A, Ji B, Meizlik P, Roth DA

Open source

DOI
10.1136/lupus-2022-000830
Published
2023 Mar
Container
Lupus science & medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/lupus-2022-000830,
  title = {Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data.},
  author = {D'Cruz D and Eriksson G and Green Y and Hammer A and Ji B and Meizlik P and Roth DA},
  year = {2023},
  journal = {Lupus science \& medicine},
  doi = {10.1136/lupus-2022-000830},
  url = {https://doi.org/10.1136/lupus-2022-000830}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data.
AU  - D'Cruz D
AU  - Eriksson G
AU  - Green Y
AU  - Hammer A
AU  - Ji B
AU  - Meizlik P
AU  - Roth DA
PY  - 2023
JO  - Lupus science & medicine
DO  - 10.1136/lupus-2022-000830
UR  - https://doi.org/10.1136/lupus-2022-000830
ER  - 

APA

D, D., G, E., Y, G., A, H., B, J., P, M., & DA, R. (2023). Safety and efficacy of belimumab in older adults with SLE: results of an integrated analysis of clinical trial data.. Lupus science & medicine. https://doi.org/10.1136/lupus-2022-000830

Source records